Detalhe da pesquisa
1.
Clinician perceptions of research priorities for the management of noncritically ill patients admitted to hospital with SARS-CoV-2 infection.
Intern Med J
; 54(2): 337-341, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38350659
2.
Peripheral administration of the Class-IIa HDAC inhibitor MC1568 partially protects against nigrostriatal neurodegeneration in the striatal 6-OHDA rat model of Parkinson's disease.
Brain Behav Immun
; 102: 151-160, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35217173
3.
LMK235, a small molecule inhibitor of HDAC4/5, protects dopaminergic neurons against neurotoxin- and α-synuclein-induced degeneration in cellular models of Parkinson's disease.
Mol Cell Neurosci
; 115: 103642, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34119632
4.
Bioinformatics and Immunohistochemical Analyses Support Preserved Expression of Glial Cell Line-Derived Neurotrophic Factor Receptor RET in Parkinson's.
Mov Disord
; 38(6): 1115-1116, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37475614
5.
Growth differentiation factor 5 exerts neuroprotection in an α-synuclein rat model of Parkinson's disease.
Brain
; 144(2): e14, 2021 03 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33253375
6.
Human α-synuclein overexpression upregulates SKOR1 in a rat model of simulated nigrostriatal ageing.
Aging Cell
; 23(6): e14155, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38529808
7.
Growth differentiation factor 5: a neurotrophic factor with neuroprotective potential in Parkinson's disease.
Neural Regen Res
; 17(1): 38-44, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34100424
8.
NME1 Protects Against Neurotoxin-, α-Synuclein- and LRRK2-Induced Neurite Degeneration in Cell Models of Parkinson's Disease.
Mol Neurobiol
; 59(1): 61-76, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34623600
9.
Quinacrine and Niclosamide Promote Neurite Growth in Midbrain Dopaminergic Neurons Through the Canonical BMP-Smad Pathway and Protect Against Neurotoxin and α-Synuclein-Induced Neurodegeneration.
Mol Neurobiol
; 58(7): 3405-3416, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33713017
10.
The potential of bone morphogenetic protein 2 as a neurotrophic factor for Parkinson's disease.
Neural Regen Res
; 15(8): 1432-1436, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31997802
11.
STRAP and NME1 Mediate the Neurite Growth-Promoting Effects of the Neurotrophic Factor GDF5.
iScience
; 23(9): 101457, 2020 Sep 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32853992
12.
Gene co-expression analysis of the human substantia nigra identifies BMP2 as a neurotrophic factor that can promote neurite growth in cells overexpressing wild-type or A53T α-synuclein.
Parkinsonism Relat Disord
; 64: 194-201, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31000327